FINWIRES · TerminalLIVE
FINWIRES

$ABT

41 stories mentioning ABTUpdated 3d ago

Every FINWIRES story that references ABT, newest first.

Wire

Freenome, Abbott Laboratories' Colorectal Cancer Screening Test Approved by FDA; Freenome Earns $100 Million Milestone Payment

Freenome (FRNM) and Abbott Laboratories (ABT) said Monday that the US Food and Drug Administration approved SimpleScreen CRC, a blood-based colorectal cancer screening test.The companies said the new blood-based screening option is intended for adults 45 and older who are at average risk for the disease.Under the terms of a commercial agreement between Freenome and Abbott, Freenome will receive a $100 million milestone payment from Abbott for the FDA approval, while Abbott will exclusively commercialize the test in the US this fall.Shares of Freenome were up close to 10% pre-bell.

$ABT$FRNM
Wire

Abbott Laboratories Seen on Track for H2 Growth Acceleration, RBC Says

Abbott Laboratories (ABT) beat Q2 expectations, with growth acceleration in the second half of 2026 remaining on track and its longer-term outlook supporting durable growth, RBC Capital Markets said.The analysts said in a note Thursday that the stock rose about 12% following the results as several investor concerns failed to materialize. These included fears of a guidance cut, weaker Nutrition performance, disruption from Exact, and slower MedTech procedure volumes.Looking ahead, the company has strong visibility into faster growth in H2. Key drivers include continued recovery in Nutrition, market share gains in Electrophysiology, easing headwinds in Core Lab as China pressures moderate, and stronger growth in Cancer Diagnostics driven by increasing Cologuard adoption.Abbott has a clear path toward the upper end of its 6.5% to 7.5% comparable sales growth guidance and has upside potential if those growth drivers continue to strengthen, according to the note.RBC reiterated its outperform rating and $130 price target on Abbott Laboratories.Shares of Abbott Laboratories were up nearly 3% in Friday trading.Price: $101.65, Change: $+2.82, Percent Change: +2.85%

$ABT
Update: Wall Street Snaps Two-Day Advance as Chip-Related Stocks Slump
US Markets

Update: Wall Street Snaps Two-Day Advance as Chip-Related Stocks Slump

(Updates with closing levels throughout the story.)Wall Street's stock indexes fell Thursday after a two-day advance, dragged down by a sell-off in chip-related stocks and certain mega-cap technology stocks.The tech-heavy Nasdaq Composite shed 1.5% to close at 25,881.95, while the S&P 500 dropped 0.5% to 7,533.77. The Dow Jones Industrial Average lost 0.2% to settle at 52,552.97.Most sectors were in the green, led by consumer staples, while communication services saw the biggest drop, followed by technology.Semiconductor company Sandisk (SNDK) was the worst performer on the S&P 500, down nearly 12%. Nvidia (NVDA) fell 2.4%, among the notable laggards on the Dow.Taiwan Semiconductor Manufacturing's (TSM) US-listed shares fell 2.3% after the semiconductor manufacturer reported its second-quarter results. The company earmarked an additional $100 billion to increase its chipmaking capacity in the US, Bloomberg News reported, citing a US official.Alphabet's (GOOGL) Class A shares slumped 4.4%, the second-worst performer on the Dow. Amazon.com (AMZN) also fell.In other corporate news, Abbott Laboratories (ABT) shares jumped nearly 11%, the biggest gainer on the S&P 500. The healthcare company lifted its full-year earnings outlook after reporting second-quarter results above market estimates.UnitedHealth (UNH) raised its full-year earnings guidance, as the health insurance giant recorded an unexpected year-over-year increase in its second-quarter revenue. The company's shares rose 1.2%.West Texas Intermediate crude oil was down 0.7% at $79.05 a barrel in Thursday late-afternoon trade, while Brent dropped 0.6% to $84.31."Oil prices slipped as traders assessed tensions between the (US) and Iran and the risks to oil supplies moving through the Strait of Hormuz," D.A. Davidson said in a note.Iran vowed to destroy key Middle East infrastructure if US President Donald Trump carries out his threat to hit Iranian infrastructure in the absence of a deal between the two countries, an Iranian military spokesperson reportedly said. Trump issued his warning in a recent interview with Fox News, CNBC reported.US Treasury yields were higher intraday, with the two-year rate up 2.3 basis points at 4.15% and the 10-year rate rising 1.4 basis points to 4.56%.Dallas Fed President Lorie Logan on Thursday pushed for "modestly higher" interest rates as she, along with her Kansas City counterpart Jeffrey Schmid, downplayed soft inflation data this week and flagged persistent price pressures.In economic news, US retail sales edged higher in June despite lower gasoline prices that drove a sharp decline in gas station receipts, official data showed.Pending home sales decreased more than projected in June amid high mortgage rates and prices, data from the National Association of Realtors showed.Homebuilder confidence deteriorated in July amid growing material prices, high land costs and elevated mortgage rates, the National Association of Home Builders and Wells Fargo said.Gold was down 1.7% at $3,983.20 per troy ounce, while silver lost 2.8% to $55.83 per ounce.

Dow JonesNasdaq CompositeS&P 500$ABT$AMZN$GOOGL$NVDA$SNDK$TSM$UNH
Japan

US Equity Markets End Lower Amid Tech Sell-Off, Iran's Threat to Block Red Sea

US equity indexes closed lower on Thursday amid a sell-off in technology stocks, and Iran threatened to close the Red Sea in case of attacks on civilian sites.* US retail sales rose by 0.2% in June, as expected in a Bloomberg-compiled poll and following the previous month's revised 1.0% increase.* US initial jobless claims fell to a level of 208,000 in the week ended July 11 from an upwardly revised 216,000 level in the previous week, compared with expectations for a level of 217,000 in a survey of analysts compiled by Bloomberg.* The Iranian military warns "all infrastructure in the region will be crushed under steel blows" if the US carries out its threat to attack Iran's civilian sites, Al Jazeera reported.* August West Texas Intermediate crude oil fell $0.84 to settle at $78.93 per barrel, while September Brent crude, the global benchmark, was last seen down $0.92 at $84.17.* Abbott Laboratories (ABT) shares were up about 11%, the top gainer on the S&P 500, after lifting its full-year earnings outlook on Thursday as the healthcare firm reported Q2 results above market estimates.* Shares of Sandisk (SNDK), Western Digital (WDC), and Seagate Technology (STX) were down as part of a larger decline in the tech sector. Sandisk shares fell 13%, Western Digital stock dropped nearly 9%, and Seagate shed roughly 10%.

Dow JonesNasdaq CompositeS&P 500$ABT$SNDK$STX$WDC
Sectors

Sector Update: Healthcare Stocks Gain Late Afternoon

Healthcare stocks were higher late Thursday afternoon, with the NYSE Healthcare Index rising 1.7% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 2%.The iShares Biotechnology ETF (IBB) was down 0.7%.In corporate news, Merck (MRK) shares gained 3% after it said Thursday that the Food and Drug Administration has approved Lipfendra 20 mg tablets as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol, or LDL-C, in adults with hypercholesterolemia, including heterozygous familial hypercholesterolemia.UnitedHealth (UNH) shares rose 1.7% after it posted higher Q2 adjusted earnings and revenue and raised its 2026 adjusted EPS outlook.AtaiBeckley (ATAI) shares surged 32% after Eli Lilly (LLY) said it agreed to acquire the clinical-stage biopharmaceutical company for up to $3.8 billion. Lilly was up 0.8%.Abbott Laboratories (ABT) lifted its full-year earnings outlook on Thursday as the healthcare firm reported Q2 results above market estimates. Abbott shares jumped past 10%.

$ABT$ATAI$LLY$MRK$UNH
Wire

Wells Fargo Raises Abbott Laboratories Price Target to $112 From $109

Abbott Laboratories (ABT) has an average rating of overweight and mean price target of $115.86, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $98.45, Change: $+9.18, Percent Change: +10.28%

$ABT
Chip Stocks Weigh on Equities Intraday; Netflix Earnings on Deck
US Markets

Chip Stocks Weigh on Equities Intraday; Netflix Earnings on Deck

US benchmark equity indexes were lower intraday amid a sell-off in certain chip-related stocks as investors parsed latest corporate earnings and awaited Netflix's (NFLX) results.The technology-heavy Nasdaq Composite was down 1.1% at 25,979.8 after midday Thursday, while the S&P 500 fell 0.5% to 7,537.8. The Dow Jones Industrial Average dropped 0.2% to 52,548. Among sectors, tech saw the steepest decline, while consumer staples paced the gainers.Sandisk (SNDK) was down 12%, the biggest drop on the S&P 500. Nvidia (NVDA) fell 2.5%, among the worst performers on the Dow.Taiwan Semiconductor Manufacturing's (TSM) US-listed shares were down 3.2% after the semiconductor manufacturer reported its second-quarter results. The company earmarked an additional $100 billion to increase its chipmaking capacity in the US, Bloomberg News reported, citing a US official.In other corporate news, Abbott Laboratories (ABT) shares jumped 11%, the biggest gainer on the S&P 500. The healthcare company lifted its full-year earnings outlook after reporting second-quarter results above market estimates.UnitedHealth (UNH) raised its full-year earnings guidance, as the health insurance giant recorded an unexpected year-over-year increase in its second-quarter revenue. The company's shares rose 3.3%, among the best performers on the Dow.Streaming giant Netflix is scheduled to report results after the closing bell Thursday.West Texas Intermediate crude oil was down 0.8% at $78.96 a barrel intraday, while Brent dropped 0.7% to $84.37."Oil prices slipped as traders assessed tensions between the (US) and Iran and the risks to oil supplies moving through the Strait of Hormuz," D.A. Davidson said in a note.Iran vowed to destroy key Middle East infrastructure if US President Donald Trump carries out his threat to hit Iranian infrastructure in the absence of a deal between the two countries, an Iranian military spokesperson reportedly said. Trump issued his warning in a recent interview with Fox News, CNBC reported.US Treasury yields were higher intraday, with the two-year rate up 3.8 basis points at 4.17% and the 10-year rate rising 2.8 basis points to 4.57%.In economic news, US retail sales edged higher in June despite lower gasoline prices that drove a sharp decline in gas station receipts, official data showed.Pending home sales decreased more than projected in June amid high mortgage rates and prices, data from the National Association of Realtors showed.Homebuilder confidence deteriorated in July amid growing material prices, high land costs and elevated mortgage rates, the National Association of Home Builders and Wells Fargo said.Gold was down 1.5% at $3,992 per troy ounce, while silver lost 2.1% to $56.22 per ounce.

Dow JonesNasdaq CompositeS&P 500$ABT$NFLX$NVDA$SNDK$TSM$UNH
Sectors

Sector Update: Healthcare Stocks Gain Thursday Afternoon

Healthcare stocks were higher Thursday afternoon, with the NYSE Healthcare Index rising 1.8% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 2%.The iShares Biotechnology ETF (IBB) was down 0.4%.In corporate news, UnitedHealth (UNH) shares rose 3.3% after it posted higher Q2 adjusted earnings and revenue and raised its 2026 adjusted EPS outlook.AtaiBeckley (ATAI) shares surged 33% after Eli Lilly (LLY) said it agreed to acquire the clinical-stage biopharmaceutical company for up to $3.8 billion. Lilly was up 1.3%.Abbott Laboratories (ABT) lifted its full-year earnings outlook on Thursday as the healthcare firm reported Q2 results above market estimates. Abbott shares jumped 11%.

$ABT$ATAI$LLY$UNH
Wire

Top Midday Stories: Taiwan Semiconductor Q2 Earnings Top Estimates, Increases Capex; UnitedHealth Raises Full-Year Guidance

The S&P 500 and Nasdaq Composite were down in late-morning trading Thursday, while the Dow Jones Industrial Average was up slightly, as Taiwan Semiconductor Manufacturing's (TSM), or TSMC's, latest earnings report dragged down chip stocks.In company news, TSMC reported Q2 earnings Thursday of 27.25 New Taiwan dollars ($0.86) per diluted share, up from NT$15.36 a year earlier and above the FactSet consensus analyst estimate of NT$24.20. Net Q2 revenue was NT$1.270 trillion, up from NT$933.79 billion a year ago and above the FactSet consensus of NT$1.266 trillion. For Q3, the chipmaker said it expects revenue of $44.6 billion to $45.8 billion, above the FactSet consensus of $43.21 billion. Separately, TSMC has reserved an additional $100 billion to increase its chipmaking capacity in the US, raising its total planned investment to $265 billion, Bloomberg reported Thursday, citing a US official. TSMC shares were down 2.1% around midday.UnitedHealth Group (UNH) reported Q2 adjusted earnings Thursday of $6.38 per diluted share, up from $4.08 a year earlier and above the FactSet consensus of $4.91. Second-quarter revenue was $112.03 billion, up from $111.62 billion a year ago and above the FactSet consensus of $110.81 billion. For 2026, the insurance company raised its adjusted EPS guidance to $19.50 to $20 from greater than $18.25. Analysts expect $18.49. UnitedHealth shares were up 3.3%.Abbott Laboratories (ABT) reported Q2 adjusted earnings Thursday of $1.31 per diluted share, up from $1.26 a year earlier and above the FactSet consensus of $1.28. Second-quarter revenue was $12.59 billion, up from $11.14 billion a year ago and above the FactSet consensus of $12.52 billion. For Q3, Abbott said it expects adjusted diluted EPS of $1.38 to $1.46, compared to the FactSet consensus of $1.42. For 2026, the company raised its adjusted EPS guidance to $5.45 to $5.60 from $5.38 to $5.58. Analysts polled by FactSet expect $5.47. Abbott shares were up 11%.Uber Technologies (UBER) on Thursday said it has entered into a business combination agreement with Delivery Hero in a deal with an equity value of $14.8 billion, or $13.7 billion adjusted for Uber's prior stake purchases. Under the terms of the deal, Delivery Hero shareholders will receive cash consideration of 41.50 euros ($47.60) per share. Uber shares were up 1.6%.GE Aerospace (GE) reported Q2 adjusted earnings Thursday of $2.02 per share, up from $1.66 a year earlier and above the FactSet consensus of $1.86. Second-quarter revenue was $13.35 billion, up from $11.02 billion a year ago and above the FactSet consensus of $11.87 billion. For 2026, the company raised its adjusted EPS guidance to $7.65 to $7.85 from $7.10 to $7.40. Analysts polled by FactSet expect $7.56. GE shares were down 4.3%.Price: $410.53, Change: $-8.95, Percent Change: -2.13%

$ABT$GE$TSM$UBER$UNH
Abbott Laboratories Raises Full-Year Earnings Guidance as Second-Quarter Results Top Views
US Markets

Abbott Laboratories Raises Full-Year Earnings Guidance as Second-Quarter Results Top Views

Abbott Laboratories (ABT) lifted its full-year earnings outlook on Thursday as the healthcare firm reported second-quarter results above market estimates.Adjusted earnings are now anticipated between $5.45 and $5.60 per share for 2026, the company said, up from its previous guidance of $5.38 to $5.58. The consensus on FactSet is for non-GAAP EPS of $5.47.Abbott continues to expect comparable sales growth of 6.5% to 7.5% for the current year. Comparable sales include the impact of Exact Sciences, a cancer diagnostics firm that Abbott acquired in March.The company's shares climbed 12% in Thursday trade, although the stock has lost 21% so far this year.For the three-month period ended June, Abbott's adjusted EPS rose to $1.31 from $1.26 the year before, surpassing the Street's view for $1.28. Sales climbed 13% to $12.59 billion, topping the average analyst estimate of $12.52 billion. Comparable sales rose 4.8%."Our second-quarter results reflect the momentum we are building," Chief Executive Robert Ford said in an earnings release. "We expect this momentum to continue and drive accelerating sales and earnings growth in the second half of the year."Diagnostics sales jumped 42% year over year to $3.09 billion, while the nutrition segment declined 3.1% to $2.14 billion amid lower volume and the impact of pricing actions taken in the fourth quarter of 2025, Abbott said. Revenue in the established pharmaceuticals division added 8.4% to almost $1.5 billion.Sales in the medical devices business grew 9% to $5.85 billion, buoyed by double-digit gains in rhythm management, electrophysiology and diabetes care, according to Abbott.For the third quarter, the company forecasts adjusted EPS of $1.38 to $1.46, while the Street is looking for $1.42.Price: $100.43, Change: $+11.16, Percent Change: +12.50%

$ABT
Sectors

Sector Update: Healthcare Stocks Rise Pre-Bell Thursday

Healthcare stocks were rising pre-bell Thursday, with the State Street Health Care Select Sector SPDR ETF (XLV) 1.2% higher and the iShares Biotechnology ETF (IBB) up 0.5%.UnitedHealth Group (UNH) stock was up more than 7% after the company posted higher Q2 adjusted earnings and revenue, and raised its 2026 adjusted EPS outlook.Abbott Laboratories (ABT) shares were up more than 5% after the company reported higher Q2 adjusted earnings and revenue, and raised its 2026 adjusted EPS guidance.Eli Lilly (LLY) has agreed to acquire AtaiBeckley (ATAI) for $2.8 billion in cash plus potential milestone payments of up to $1.0 billion, the companies said. AtaiBeckley stock was up more than 33% pre-bell.

$ABT$ATAI$IBB$LLY$UNH$XLV
Stocks Mostly Down Pre-Bell as Investors Await More Earnings, Retail Sales Data
US Markets

Stocks Mostly Down Pre-Bell as Investors Await More Earnings, Retail Sales Data

US equity markets were mostly tracking in the red before the opening bell Thursday as traders await the latest round of earnings and the June retail sales report.The S&P 500 edged down 0.1% and the Nasdaq was off 0.5% in premarket activity, while the Dow Jones Industrial Average rose 0.2%. The three main indexes finished Wednesday trading higher for the second consecutive session.UnitedHealth (UNH), GE Aerospace (GE), Abbott Laboratories (ABT), Prologis (PLD), US Bancorp (USB), State Street (STT) and Citizens Financial (CFG) are expected to report their latest financial results before the bell, among others. Streaming giant Netflix (NFLX) posts its earnings after the markets close.Taiwan Semiconductor Manufacturing's (TSM) US-listed shares declined 3.9% pre-bell after the semiconductor manufacturer reported its second-quarter results. United Airlines (UAL) was down 2.3% as the air carrier flagged an additional $6 billion in fuel costs for 2026 amid rising oil prices.J.B. Hunt Transport Services (JBHT) jumped 6.4% as the transportation and logistics company's second-quarter results topped market estimates. Apple (AAPL) added 0.2% after finishing Wednesday with a 4% gain amid media reports that the iPhone maker has held talks with bankers in recent months about possible acquisitions of chip companies.Last month's retail sales report is out at 8:30 am ET.Government data showed Wednesday that producer prices unexpectedly dropped on a monthly basis in June amid a steep decline in the cost of energy products. Earlier in the week, an official report showed that consumer prices decreased last month for the first time in more than six years."While still nominally elevated at a dangerously high level, the relative improvement in inflation in June emboldens the more dovish argument that price pressures are already cooling and could retreat further into year-end as the lingering impact from tariffs falls off and energy prices potentially normalize amid -- still tentative -- but ongoing, US-Iran peace negotiations," Stifel said in a note Wednesday.US Treasury yields were up in premarket action, with the two-year rate increasing 3.2 basis points to 4.16% and the 10-year rate adding 2.8 basis points to 4.57%.Thursday's economic calendar also has the weekly jobless claims bulletin at 8:30 am, along with the Philadelphia Fed manufacturing index for July. The housing market index for the current month and the pending home sales index for June are both out at 10 am.Federal Reserve Vice Chair Philip Jefferson, Dallas Fed President Lorie Logan and Kansas City Fed President Jeffrey Schmid are all slated to speak on Thursday.Inflation is more likely to accelerate than cool given price pressures arising from an artificial intelligence boom and major supply shocks, Fed Governor Lisa Cook said Wednesday. Separately, New York Fed President John Williams said that inflation should ease in the next few quarters as energy prices retreat.West Texas Intermediate crude oil dipped less than 0.1% to $79.59 a barrel before the open, while Brent nudged down 0.3% to $84.72.The US Central Command said Wednesday its forces disabled an unladen oil tanker attempting to transit towards an Iranian port in the Arabian Gulf. The US resumed its naval blockade on Iranian ships and ports earlier this week.A spokesperson for Iran's top military command reportedly said Thursday that it will destroy key infrastructure in the Middle East if the US follows through on President Donald Trump's threat to attack power plants and bridges in the country in case a deal isn't finalized, CNBC reported.Gold decreased 0.3% to $4,039 per troy ounce, while bitcoin fell 1.1% to $64,176.

Dow JonesNasdaq CompositeS&P 500$AAPL$ABT$CFG$GE$JBHT$NFLX$PLD$STT$TSM$UAL$UNH$USB
Research

Baird Initiates Abbott Laboratories at Outperform With $121 Price Target

Abbott Laboratories (ABT) has an average rating of overweight and mean price target of $115.74, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$ABT
Sectors

Sector Update: Healthcare Stocks Higher Late Afternoon

Healthcare stocks were higher late Monday afternoon, with the NYSE Healthcare Index up 0.1% and the State Street Health Care Select Sector SPDR ETF (XLV) gaining 0.2%.The iShares Biotechnology ETF (IBB) rose 0.9%.In corporate news, Zymeworks (ZYME) has agreed to buy Theravance Biopharma (TBPH) for $17 per share in a roughly $929 million deal, the companies said in separate statements. Zymeworks shares were down 0.6%, and Theravance fell 3.2%.Abbott Laboratories (ABT) shares were down 1.3%. The Wall Street Journal reported Sunday the company will not face criminal charges after the US Department of Justice closed a years-long investigation into its baby formula operations.QuidelOrtho (QDEL) shares surged 34%. The company is weighing the sale of its point-of-care testing business behind rapid COVID-19 antigen tests for about $1.5 billion, the Financial Times reported Saturday.Alkermes (ALKS) stock has been re-rated following a recent orexin-peer takeout, but upcoming orexin updates risk eroding newly ascribed orexin-related value, BofA Securities said in a note Monday. BofA downgraded Alkermes to underperform from neutral with a price target of $38. Shares were down 4.7%.

$ABT$ALKS$QDEL$TBPH$ZYME
Sectors

Sector Update: Healthcare Stocks Softer in Afternoon Trading

Healthcare stocks were lower Monday afternoon, with the NYSE Healthcare Index decreasing 0.3% and the State Street Health Care Select Sector SPDR ETF (XLV) down 0.2%.The iShares Biotechnology ETF (IBB) rose 0.4%.In corporate news, Abbott Laboratories (ABT) shares were down 0.6%. The Wall Street Journal reported Sunday the company will not face criminal charges after the US Department of Justice closed a years-long investigation into its baby formula operations.Zymeworks (ZYME) has agreed to buy Theravance Biopharma (TBPH) for $17 per share in a roughly $929 million deal, the companies said in separate statements. Zymeworks shares were down 1%, and Theravance fell 2.3%.QuidelOrtho (QDEL) shares surged 34%. The company is weighing the sale of its point-of-care testing business behind rapid COVID-19 antigen tests for about $1.5 billion, the Financial Times reported Saturday.

$ABT$QDEL$TBPH$ZYME
Sectors

Sector Update: Healthcare

Healthcare stocks edged lower Monday afternoon, with the NYSE Healthcare Index fractionally lower and the State Street Health Care Select Sector SPDR ETF (XLV) down 0.2%.The iShares Biotechnology ETF (IBB) increased 0.2%.In corporate news, Abbott Laboratories (ABT) shares were down 0.2%. The Wall Street Journal reported Sunday the company will not face criminal charges after the US Department of Justice closed a years-long investigation into its baby formula operations.

$ABT
Wire

Abbott Laboratories Keeps Quarterly Dividend at $0.63 a Share, Payable Aug. 17 to Holders of Record as of July 15

Abbott Laboratories Keeps Quarterly Dividend at $0.63 a Share, Payable Aug. 17 to Holders of Record as of July 15

$ABT
Wire

Abbott Gets CE Mark for Glucose-Ketone Sensing Technology for Diabetes

Abbott (ABT) said Wednesday it has secured the CE Mark for its dual glucose-ketone sensing technology for people with diabetes.The systems, branded as Libre Duo and Libre Duo 10 Day, are designed to continuously measure glucose and ketone levels every minute, the company said.Abbott said it plans to start launching Libre Duo systems in some European countries later this year.Price: $86.44, Change: $-0.23, Percent Change: -0.27%

$ABT
Wire

Abbott Laboratories Says Ultreon 3.0 Coronary Imaging Software Receives FDA Clearance, CE Mark

Abbott Laboratories (ABT) said Tuesday that it received US Food and Drug Administration clearance and the European Union's CE Mark for its Ultreon 3.0 artificial intelligence-powered coronary imaging software.The software uses optical coherence tomography to support doctors performing minimally invasive procedures to open blocked heart arteries, known as percutaneous coronary intervention, the company said.Abbott said the software helps doctors choose the best stent location and size to improve blood flow, thereby enabling faster, more precise procedures.Shares of the company were up 1.1% in Tuesday's trading.Price: $93.58, Change: $+0.78, Percent Change: +0.84%

$ABT
Research

Daiwa Downgrades Abbott Laboratories to Neutral From Outperform, Adjusts PT to $92 From $113

Abbott Laboratories (ABT) has an average rating of overweight and mean price target of $119.08, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$ABT

Showing 1-20 of 41

Track with the FINWIRES app suite

FolioX
FolioX
Track ABT in your portfolio
WheelAI
WheelAI
Analyze ABT options with the wheel strategy
StockInsider
StockInsider
See market sentiment on ABT